CG
NDRM

Cutler Group’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Cutler Group’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-49,300
Closed -$815K – 6758
2017
Q3 		$815K Sell
49,300
-19,700
-29% -$725K 0.03% 425
2017
Q2 		$462K Buy
+69,000
New +$1.79M 0.02% 736

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Cutler Group's NDRM Position: Q3 2017 in Review

Cutler Group sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q3 2017, closing a stake of 100 shares — an estimated $3.68K sold.

Cutler Group first reported a position in NDRM in Q2 2017 and held it in 1 quarter. The position peaked at $2K in Q2 2017. 81 funds tracked by Wall St. Rank hold NDRM as of Q3 2017.

  • Cutler Group reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q3 2017 after selling out during the quarter.
  • Cutler Group sold 100 NeuroDerm Ltd. Ordinary Shares shares in Q3 2017, an estimated $3.68K.
  • Cutler Group first reported a position in NeuroDerm Ltd. Ordinary Shares in Q2 2017 and held it in 1 quarter.
  • Cutler Group's NeuroDerm Ltd. Ordinary Shares position peaked at $2K in Q2 2017.
  • 81 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q3 2017.

Based on Cutler Group's 13F filing for Q3 2017, filed 17 Oct 2017.